All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Top results
Relapsed or Refractory EGFR NSCLC
Feb 20, 2017
onclive.com
Treatment Options for EGFR NSCLC
30 views
Jun 30, 2023
vumedi.com
Overcoming Resistance in EGFR NSCLC
201 views
Jul 3, 2023
vumedi.com
EGFR-Targeted Therapy in Advanced NSCLC Patients With Uncommon EGFR Mutations
106 views
Jun 21, 2023
vumedi.com
Testing for EGFR in NSCLC Worldwide
Oct 20, 2020
onclive.com
Optimizing Therapy Selection in EGFR Mutant NSCLC
6 months ago
onclive.com
Future Outlook of EGFR Mutant NSCLC
Jan 10, 2022
onclive.com
3:51
Treatment Options for EGFR-Mutated NSCLC Following Progression
Oct 12, 2023
onclive.com
EGFR Inhibitors as Adjuvant Therapy in NSCLC
Oct 20, 2018
onclive.com
ESMO 2023 Insights: "The Latest in NSCLC With Common EGFR Mutations"
298 views
Oct 26, 2023
vumedi.com
ESMO 2023 Insights: "Latest in EGFR Ex20ins Advanced NSCLC"
187 views
Oct 26, 2023
vumedi.com
5:48
EGFR-Mutated NSCLC: Treatment Options Following Progression on Osimertinib
Oct 19, 2023
onclive.com
Targeted Therapies in Lung Cancer 2023: EGFR Targeted Therapies in NSCLC
387 views
Aug 26, 2023
vumedi.com
Overview of EGFR Mutations and Clinical Activity of Amivantamab in NSCLC
115 views
Jul 8, 2023
vumedi.com
Uncommon EGFR Mutations in NSCLC: Future Directions in Care
Jul 21, 2023
onclive.com
2021 ASCO Review on EGFR Resistance Strategies in NSCLC: Amivantamab & Lazertinib Data
261 views
Nov 21, 2021
vumedi.com
New Standard for Treating Stage 4 EGFR NSCLC
Mar 1, 2018
onclive.com
Selecting Therapy for Advanced NSCLC With EGFR Mutations
Jul 26, 2022
onclive.com
Treatment Options for Patients with NSCLC with EGFR Mutations
Aug 29, 2023
onclive.com
EGFR-Targeted Therapy for Squamous NCSLC
Feb 21, 2017
onclive.com
Second- and Third-Generation TKIs in EGFR-Mutated NSCLC
Jun 4, 2019
onclive.com
Updates in Treatment of NSCLC with Classical EGFR Mutations
May 2, 2022
onclive.com
NSCLC Targeted Therapies Update: Should We Consider EGFR Targeted Therapy in Adjuvant Setting?
159 views
Apr 22, 2021
vumedi.com
Latest Overall Survival Analyses in Resected EGFR-Mutated NSCLC
Jul 24, 2023
onclive.com
Dr Jänne on an Exploratory Analysis from FLAURA2 of Baseline ctDNA in EGFR NSCLC
10 months ago
onclive.com
Selecting Second-Line Treatment for EGFR-Mutated Advanced NSCLC
Sep 9, 2022
cancernetwork.com
Expert Analysis of 1L EGFR Advanced NSCLC Options: 1st Gen Gefitinib & Erlotinib, 2nd Gen Afatinib & Dacomitinib, 3rd Gen Osimertinib, Combos With VEGF or Chemo, Exon 20 Insertions
204 views
Jul 1, 2021
vumedi.com
3:29
Treatment Options in EGFR-Mutant NSCLC in Second Line and Beyond
Dec 20, 2023
onclive.com
ESMO Asia 2023 Insights: "EGFR TKIs in NSCLC - Which One, How Long, When, and Who"
40 views
Jan 4, 2024
vumedi.com
Dacomitinib: Dark Horse EGFR TKI Charges into First Line Setting for Advanced NSCLC
131 views
May 20, 2020
vumedi.com
See more videos
Feedback
Feedback